Table 2.
Overview of clinical trials based on antibody combinations.
| Mab | Status | Phase | ClinicalTrials.Gov Identifier |
|---|---|---|---|
| VRC01+ VRC01LS | Completed, with results | Phase 1 | NCT02797171 |
| VRC01+ VRC01LS + VRC07-523LS | Active, not recruiting | Phase 1 | NCT02256631 |
| 3BNC117 + 10-1074 |
Completed, without results | Phase 1 | NCT02824536, NCT02825797 |
| 3BNC117-LS + 10-1074 |
Completed, without results | Phase 1 | NCT03554408 |
| 3BNC117-LS + 10-1074-LS | Active, not recruiting | Phase 1 | NCT04250636 |
| 3BNC117 + 10-1074 + peg-IFN-α2b |
Active, not recruiting | Phase 1 | NCT03588715 |
| 3BNC117 + 10-1074 |
Active, not recruiting | Phase 1 | NCT03526848 |
| VRC07-523LS + 10-1074 + PGT121 + PGDM1400 |
Completed, without results | Phase 1 | NCT03928821 |
| VRC07-523LS + 10-1074 + N-803 |
Recruiting | Phase 1 | NCT04340596 |